Technical Analysis for ADTX - ADiTx Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Up |
| Historical ADTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Weak + Overbought | Other | -3.07% | |
| Wide Bands | Range Expansion | -3.07% | |
| Overbought Stochastic | Strength | -3.07% | |
| Narrow Range Bar | Range Contraction | 2.79% | |
| Weak + Overbought | Other | 2.79% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 3x Volume Pace | 2 days ago | |
| 2x Volume Pace | 2 days ago | |
| 1.5x Volume Pace | 2 days ago | |
| Down 5% | 2 days ago | |
| Down 3% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Aditx Therapeutics, Inc., is developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system.
Medicine Immunology Immunotherapy Immune System Autoimmune Diseases Autoimmunity Autoimmune Disease Allergies
Medicine Immunology Immunotherapy Immune System Autoimmune Diseases Autoimmunity Autoimmune Disease Allergies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.58 |
| 52 Week Low | 1.1 |
| Average Volume | 840,392 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 2.52 |
| 20-Day Moving Average | 1.96 |
| 10-Day Moving Average | 2.08 |
| Average True Range | 0.24 |
| ADX | 26.53 |
| +DI | 20.64 |
| -DI | 25.17 |
| Chandelier Exit (Long, 3 ATRs ) | 1.63 |
| Chandelier Exit (Short, 3 ATRs ) | 1.82 |
| Upper Bollinger Band | 2.43 |
| Lower Bollinger Band | 1.49 |
| Percent B (%b) | 0.76 |
| BandWidth | 47.76 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.15 |
| MACD Histogram | 0.0902 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.42 | ||||
| Resistance 3 (R3) | 2.42 | 2.34 | 2.39 | ||
| Resistance 2 (R2) | 2.34 | 2.29 | 2.35 | 2.37 | |
| Resistance 1 (R1) | 2.28 | 2.26 | 2.24 | 2.28 | 2.36 |
| Pivot Point | 2.20 | 2.20 | 2.19 | 2.21 | 2.20 |
| Support 1 (S1) | 2.14 | 2.15 | 2.10 | 2.14 | 2.06 |
| Support 2 (S2) | 2.06 | 2.12 | 2.07 | 2.05 | |
| Support 3 (S3) | 2.00 | 2.06 | 2.04 | ||
| Support 4 (S4) | 2.00 |
